BACKGROUND: Despite recognition of the benefits associated with well-controlled diabetes and hypertension, control remains suboptimal. Effective interventions for these conditions have been studied within academic settings, but interventions targeting both conditions have rarely been tested in community settings. We describe the design and baseline results of a trial evaluating a behavioral intervention among community patients with poorly-controlled diabetes and comorbid hypertension. METHODS: Tailored Case Management for Diabetes and Hypertension (TEACH-DM) is a 24-month randomized, controlled trial evaluating a telephone-delivered behavioral intervention for diabetes and hypertension versus attention control. The study recruited from nine community practices. The nurse-administered intervention targets 3 areas: 1) cultivation of healthful behaviors for diabetes and hypertension control; 2) provision of fundamentals to support attainment of healthful behaviors; and 3) identification and correction of patient-specific barriers to adopting healthful behaviors. HemoglobinA1c and blood pressure measured at 6, 12, and 24 months are co-primary outcomes. Secondary outcomes include self-efficacy, self-reported medication adherence, exercise, and cost-effectiveness. RESULTS: Of 377 randomized patients, 193 were allocated to the intervention and 184 to attention control. The cohort is balanced in terms of gender, race, education level, and income. The cohort's mean baseline hemoglobinA1c and blood pressure are above goal, and mean baseline body mass index falls in the obese range. Baseline self-reported non-adherence is high for diabetes and hypertension medications. Trial results are pending. CONCLUSIONS: If effective, the TEACH-DM intervention's telephone-based delivery strategy and nurse administration make it well-suited for rapid implementation and broad dissemination in community settings.
RCT Entities:
BACKGROUND: Despite recognition of the benefits associated with well-controlled diabetes and hypertension, control remains suboptimal. Effective interventions for these conditions have been studied within academic settings, but interventions targeting both conditions have rarely been tested in community settings. We describe the design and baseline results of a trial evaluating a behavioral intervention among community patients with poorly-controlled diabetes and comorbid hypertension. METHODS: Tailored Case Management for Diabetes and Hypertension (TEACH-DM) is a 24-month randomized, controlled trial evaluating a telephone-delivered behavioral intervention for diabetes and hypertension versus attention control. The study recruited from nine community practices. The nurse-administered intervention targets 3 areas: 1) cultivation of healthful behaviors for diabetes and hypertension control; 2) provision of fundamentals to support attainment of healthful behaviors; and 3) identification and correction of patient-specific barriers to adopting healthful behaviors. Hemoglobin A1c and blood pressure measured at 6, 12, and 24 months are co-primary outcomes. Secondary outcomes include self-efficacy, self-reported medication adherence, exercise, and cost-effectiveness. RESULTS: Of 377 randomized patients, 193 were allocated to the intervention and 184 to attention control. The cohort is balanced in terms of gender, race, education level, and income. The cohort's mean baseline hemoglobin A1c and blood pressure are above goal, and mean baseline body mass index falls in the obese range. Baseline self-reported non-adherence is high for diabetes and hypertension medications. Trial results are pending. CONCLUSIONS: If effective, the TEACH-DM intervention's telephone-based delivery strategy and nurse administration make it well-suited for rapid implementation and broad dissemination in community settings.
Authors: Marion J Franz; John P Bantle; Christine A Beebe; John D Brunzell; Jean-Louis Chiasson; Abhimanyu Garg; Lea Ann Holzmeister; Byron Hoogwerf; Elizabeth Mayer-Davis; Arshag D Mooradian; Jonathan Q Purnell; Madelyn Wheeler Journal: Diabetes Care Date: 2003-01 Impact factor: 19.112
Authors: Edward H Wagner; Katie Coleman; Robert J Reid; Kathryn Phillips; Melinda K Abrams; Jonathan R Sugarman Journal: Prim Care Date: 2012-04-24 Impact factor: 2.907
Authors: David Edelman; Rowena J Dolor; Cynthia J Coffman; Katherine C Pereira; Bradi B Granger; Jennifer H Lindquist; Alice M Neary; Amy J Harris; Hayden B Bosworth Journal: J Gen Intern Med Date: 2015-01-08 Impact factor: 5.128
Authors: Gerald S Bloomfield; Tracy Y Wang; L Ebony Boulware; Robert M Califf; Adrian F Hernandez; Eric J Velazquez; Eric D Peterson; Jennifer S Li Journal: Glob Heart Date: 2015-03
Authors: Louise Foley; James Larkin; Richard Lombard-Vance; Andrew W Murphy; Lisa Hynes; Emer Galvin; Gerard J Molloy Journal: BMJ Open Date: 2021-09-02 Impact factor: 3.006
Authors: Kelly Moore; Luohua Jiang; Spero M Manson; Janette Beals; William Henderson; Katherine Pratte; Kelly J Acton; Yvette Roubideaux Journal: Am J Public Health Date: 2014-09-11 Impact factor: 9.308
Authors: Elizabeth A Kobe; Allison A Lewinski; Amy S Jeffreys; Valerie A Smith; Cynthia J Coffman; Susanne M Danus; Elisabeth Sidoli; Beth D Greck; Leanne Horne; David R Saxon; Susan Shook; Lina E Aguirre; Mary G Esquibel; Clarene Evenson; Christopher Elizagaray; Vivian Nelson; Amanda Zeek; William G Weppner; Stephanie Scodellaro; Cassie J Perdew; George L Jackson; Karen Steinhauser; Hayden B Bosworth; David Edelman; Matthew J Crowley Journal: J Gen Intern Med Date: 2022-01-03 Impact factor: 6.473
Authors: Elizabeth A Kobe; David Edelman; Phillip E Tarkington; Hayden B Bosworth; Matthew L Maciejewski; Karen Steinhauser; Amy S Jeffreys; Cynthia J Coffman; Valerie A Smith; Elizabeth M Strawbridge; Steven T Szabo; Shivan Desai; Mary P Garrett; Theresa C Wilmot; Teresa J Marcano; Donna L Overby; Glenda A Tisdale; Melissa Durkee; Susan Bullard; Moahad S Dar; Amy C Mundy; Janette Hiner; Sonja K Fredrickson; Nadya T Majette Elliott; Teresa Howard; Deborah H Jeter; Susanne Danus; Matthew J Crowley Journal: Contemp Clin Trials Date: 2020-09-21 Impact factor: 2.226